Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Depression

Free Subscription Articles published in Pharmacol Biochem Behav Retrieve available abstracts of 58 articles: HTML format

Single Articles

June 2024
1. YANG Y, Zhou D, Min S, Liu D, et al
   Ciprofol ameliorates ECS-induced learning and memory impairment by modulating aerobic glycolysis in the hippocampus of depressive-like rats.
   Pharmacol Biochem Behav. 2024;239:173775.
   PubMed     Abstract available
   
   
   
2. JIANG H, Zhang M, Wang HQ, Zhang NN, et al
   Inflammation and Connexin 43 profiles in the prefrontal cortex are relevant to stress susceptibility and resilience in mice.
   Pharmacol Biochem Behav. 2024;239:173757.
   PubMed     Abstract available
   
   
   May 2024
3. MA L, Eguchi A, Liu G, Qu Y, et al
   A role of gut-brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress.
   Pharmacol Biochem Behav. 2024;238:173736.
   PubMed     Abstract available
   
   
   April 2024
4. ZHENG JY, Li XX, Liu X, Zhang CC, et al
   Fluoxetine reverses early-life stress-induced depressive-like behaviors and region-specific alterations of monoamine transporters in female mice.
   Pharmacol Biochem Behav. 2024;237:173722.
   PubMed     Abstract available
   
   
   March 2024
5. LI Y, Luo Y, Zhu P, Liang X, et al
   Running exercise improves astrocyte loss, morphological complexity and astrocyte-contacted synapses in the hippocampus of CUS-induced depression model mice.
   Pharmacol Biochem Behav. 2024 Mar 15:173750. doi: 10.1016/j.pbb.2024.173750.
   PubMed     Abstract available
   
   
   
6. BEGEGA A, Lopez M, Cuesta-Lopez I, Jove CI, et al
   Physical activity as a promoter of stress resilience: An analysis of behavioral effects and brain connectivity with cytochrome c-oxidase activity in adult male Wistar rats.
   Pharmacol Biochem Behav. 2024;236:173709.
   PubMed     Abstract available
   
   
   February 2024
7. SHARMA R, Bansal P, Saini L, Sharma N, et al
   Zuranolone, a neuroactive drug, used in the treatment of postpartum depression by modulation of GABA(A) receptors.
   Pharmacol Biochem Behav. 2024 Feb 20:173734. doi: 10.1016/j.pbb.2024.173734.
   PubMed     Abstract available
   
   
   December 2023
8. BRANDAO AAC, Deus DLS, Duarte-Filho LAMS, Menezes PMN, et al
   Nebulized and intraperitoneal ketamine have equivalent antidepressant-like effect in the forced swim and tail suspension tests in mice.
   Pharmacol Biochem Behav. 2023;233:173674.
   PubMed     Abstract available
   
   
   
9. LIU G, Ma L, Qu Y, Wan X, et al
   Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress.
   Pharmacol Biochem Behav. 2023;233:173659.
   PubMed     Abstract available
   
   
   November 2023
10. HIROSE Y, Oda Y, Yoshino K, Yano F, et al
    Reduction of claudin-5 and aquaporin-4 in the rat hippocampal CA-1 and CA-3 regions of a learned helplessness model of depression.
    Pharmacol Biochem Behav. 2023 Nov 20:173676. doi: 10.1016/j.pbb.2023.173676.
    PubMed     Abstract available
    
    
    
11. LIU F, Tian Q, Tang HL, Cheng X, et al
    Hydrogen sulfide attenuates depression-like behaviours in Parkinson's disease model rats by improving synaptic plasticity in a hippocampal Warburg effect-dependent manner.
    Pharmacol Biochem Behav. 2023 Nov 13:173677. doi: 10.1016/j.pbb.2023.173677.
    PubMed     Abstract available
    
    
    September 2023
12. IBI D, Nakasai G, Sawahata M, Takaba R, et al
    Emotional behaviors as well as the hippocampal reelin expression in C57BL/6N male mice chronically treated with corticosterone.
    Pharmacol Biochem Behav. 2023;230:173617.
    PubMed     Abstract available
    
    
    
13. QIN Y, Li H, Zhang Y, Cao JL, et al
    Retigabine promotes ketamine's antidepressant effect in the forced swim test in male and female C57BL/6J mice.
    Pharmacol Biochem Behav. 2023;230:173590.
    PubMed     Abstract available
    
    
    July 2023
14. ELDER HJ, Walentiny DM, Beardsley PM
    Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
    Pharmacol Biochem Behav. 2023;229:173601.
    PubMed     Abstract available
    
    
    June 2023
15. WHITE SW, Squires GD, Smith SJ, Wright GM, et al
    Anxiolytic-like effects of an mGluR 5 antagonist and a mGluR 2/3 agonist, and antidepressant-like effects of an mGluR 7 agonist in the chick social separation stress test, a dual-drug screening model of treatment-resistant depression.
    Pharmacol Biochem Behav. 2023 Jun 20:173588. doi: 10.1016/j.pbb.2023.173588.
    PubMed     Abstract available
    
    
    May 2023
16. VARSHNEYA NB, Hassanien SH, Holt MC, Stevens DL, et al
    Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression.
    Pharmacol Biochem Behav. 2023;226:173572.
    PubMed     Abstract available
    
    
    
17. MEDINA-RODRIGUEZ EM, Cruz AA, De Abreu JC, Beurel E, et al
    Stress, inflammation, microbiome and depression.
    Pharmacol Biochem Behav. 2023 May 4:173561. doi: 10.1016/j.pbb.2023.173561.
    PubMed     Abstract available
    
    
    February 2023
18. ONISIFOROU A, Georgiou P, Zanos P
    Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions.
    Pharmacol Biochem Behav. 2023;223:173531.
    PubMed     Abstract available
    
    
    
19. HERNANDEZ-HERNANDEZ E, Ledesma-Corvi S, Yanez-Gomez F, Garau C, et al
    Sex differences in the antidepressant-like response and molecular events induced by the imidazoline-2 receptor agonist CR4056 in rats.
    Pharmacol Biochem Behav. 2023;223:173527.
    PubMed     Abstract available
    
    
    
20. SCOTTON E, Casa PL, de Abreu FP, de Avila E Silva S, et al
    Differentially regulated targets in the fast-acting antidepressant effect of (R)-ketamine: A systems biology approach.
    Pharmacol Biochem Behav. 2023;223:173523.
    PubMed     Abstract available
    
    
    December 2022
21. QU Y, Chang L, Ma L, Wan X, et al
    Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice.
    Pharmacol Biochem Behav. 2022;222:173500.
    PubMed     Abstract available
    
    
    October 2022
22. CARLESSI AS, Botelho MEM, Manosso LM, Borba LA, et al
    Sex differences on the response to antidepressants and psychobiotics following early life stress in rats.
    Pharmacol Biochem Behav. 2022;220:173468.
    PubMed     Abstract available
    
    
    
23. PALUCHA-PONIEWIERA A
    The role of mGlu2/3 receptor antagonists in the enhancement of the antidepressant-like effect of ketamine.
    Pharmacol Biochem Behav. 2022;220:173454.
    PubMed     Abstract available
    
    
    September 2022
24. DE MELO MARTINS GM, Pettersen B, Rubensam G, da Silva JMK, et al
    Physical exercise prevents behavioral alterations in a reserpine-treated zebrafish: A putative depression model.
    Pharmacol Biochem Behav. 2022 Sep 2:173455. doi: 10.1016/j.pbb.2022.173455.
    PubMed     Abstract available
    
    
    
25. SAADATI N, Bananej M, Khakpai F, Zarrindast MR, et al
    Synergistic antidepressant effects of citalopram and SB-334867 in the REM sleep-deprived mice: Possible role of BDNF.
    Pharmacol Biochem Behav. 2022;219:173449.
    PubMed     Abstract available
    
    
    August 2022
26. PU Y, He Y, Zhao X, Zhang Q, et al
    Depression-like behaviors in mouse model of Sjogren's syndrome: A role of gut-microbiota-brain axis.
    Pharmacol Biochem Behav. 2022;219:173448.
    PubMed     Abstract available
    
    
    July 2022
27. DE ARRUDA CM, Doneda DL, de Oliveira VV, da Silva RAL, et al
    Involvement of kynurenine pathway and N-methyl-d-aspartate receptors in the antidepressant-like effect of vilazodone in the tail suspension test in mice.
    Pharmacol Biochem Behav. 2022;218:173433.
    PubMed     Abstract available
    
    
    
28. CAMARGO A, Rodrigues ALS
    Guanosine as a promising target for fast-acting antidepressant responses.
    Pharmacol Biochem Behav. 2022;218:173422.
    PubMed     Abstract available
    
    
    February 2022
29. D'SOUZA MS, Seeley SL, Emerson N, Rose-Malkamaki MJ, et al
    Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2.
    Pharmacol Biochem Behav. 2022;213:173338.
    PubMed     Abstract available
    
    
    
30. CHEN YM, Lin CH, Lane HY
    Distinctively lower DISC1 mRNA levels in patients with schizophrenia, especially in those with higher positive, negative, and depressive symptoms.
    Pharmacol Biochem Behav. 2022;213:173335.
    PubMed     Abstract available
    
    
    January 2022
31. DONG C, Tian Z, Fujita Y, Fujita A, et al
    Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
    Pharmacol Biochem Behav. 2022;212:173316.
    PubMed     Abstract available
    
    
    December 2021
32. FUREIX C, Trevarthen AC, Finnegan EM, Buckova K, et al
    Do greater levels of in-cage waking inactivity in laboratory mice reflect a spontaneous depression-like symptom? A pharmacological investigation.
    Pharmacol Biochem Behav. 2021;212:173311.
    PubMed     Abstract available
    
    
    
33. LEUSSIS MP, Thanos JM, Powers A, Peterson E, et al
    Sex differences in long-term behavioral alterations, especially anxiety, following prenatal fluoxetine exposure in C57BL/6 mice.
    Pharmacol Biochem Behav. 2021;211:173293.
    PubMed     Abstract available
    
    
    
34. HARA H, Suzuki A, Kunugi A, Tajima Y, et al
    TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Pharmacol Biochem Behav. 2021;211:173289.
    PubMed     Abstract available
    
    
    
35. SUN L, Wang G, Wu Z, Xie Y, et al
    Swimming exercise reduces the vulnerability to stress and contributes to the AKT/GSK3beta/CRMP2 pathway and microtubule dynamics mediated protective effects on neuroplasticity in male C57BL/6 mice.
    Pharmacol Biochem Behav. 2021;211:173285.
    PubMed     Abstract available
    
    
    September 2021
36. FENG C, Ren Y, Zhou J, Dong Y, et al
    Cross-fostering alleviates depression-like behavior mediated by EAAT2 and SNARE complex in prenatal stress offspring rat.
    Pharmacol Biochem Behav. 2021 Sep 3:173269. doi: 10.1016/j.pbb.2021.173269.
    PubMed     Abstract available
    
    
    
37. ZHANG F, Hillhouse TM, Anderson PM, Koppenhaver PO, et al
    Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice.
    Pharmacol Biochem Behav. 2021;208:173228.
    PubMed     Abstract available
    
    
    July 2021
38. WANG Y, Jiang R, Wu Z, Zhou L, et al
    Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression.
    Pharmacol Biochem Behav. 2021;207:173226.
    PubMed     Abstract available
    
    
    June 2021
39. ZOLFAGHARI FS, Pirri F, Gauvin E, Peeri M, et al
    Exercise and fluoxetine treatment during adolescence protect against early life stress-induced behavioral abnormalities in adult rats.
    Pharmacol Biochem Behav. 2021;205:173190.
    PubMed     Abstract available
    
    
    May 2021
40. REDDY BR, Babu NS, Das T, Bhattacharya D, et al
    Proteome profile of telencephalon associates attenuated neurogenesis with chronic stress induced mood disorder phenotypes in zebrafish model.
    Pharmacol Biochem Behav. 2021;204:173170.
    PubMed     Abstract available
    
    
    April 2021
41. HORMAN T, Ayoub S, Leri F
    Evidence of hypoglycemic anhedonia and modulation by bupropion in rats.
    Pharmacol Biochem Behav. 2021;203:173120.
    PubMed     Abstract available
    
    
    March 2021
42. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats.
    Pharmacol Biochem Behav. 2021 Mar 3:173156. doi: 10.1016/j.pbb.2021.173156.
    PubMed     Abstract available
    
    
    
43. GAO TH, Ni RJ, Liu S, Tian Y, et al
    Chronic lithium exposure attenuates ketamine-induced mania-like behavior and c-Fos expression in the forebrain of mice.
    Pharmacol Biochem Behav. 2021;202:173108.
    PubMed     Abstract available
    
    
    February 2021
44. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Retraction notice to "Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats" [Pharmacol. Biochem. Behav. 194 (2020) 172939].
    Pharmacol Biochem Behav. 2021;203:173130.
    PubMed     Abstract available
    
    
    January 2021
45. TAFSEER S, Gupta R, Ahmad R, Jain S, et al
    Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder.
    Pharmacol Biochem Behav. 2021;200:173073.
    PubMed     Abstract available
    
    
    November 2020
46. LIU R, Wu XM, He X, Wang RZ, et al
    Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: Reversal by ketamine.
    Pharmacol Biochem Behav. 2020 Nov 24:173079. doi: 10.1016/j.pbb.2020.173079.
    PubMed     Abstract available
    
    
    
47. NEIS VB, Moretti M, Rosa PB, Dalsenter YO, et al
    The involvement of PI3K/Akt/mTOR/GSK3beta signaling pathways in the antidepressant-like effect of AZD6765.
    Pharmacol Biochem Behav. 2020;198:173020.
    PubMed     Abstract available
    
    
    October 2020
48. CHRISSOBOLIS S, Luu A, Waldschmidt R, Yoakum M, et al
    Targeting the renin angiotensin system for the treatment of anxiety and depression.
    Pharmacol Biochem Behav. 2020 Oct 25:173063. doi: 10.1016/j.pbb.2020.173063.
    PubMed     Abstract available
    
    
    
49. SAAVEDRA JS, Garrett PI, Honeycutt SC, Peterson AM, et al
    Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
    Pharmacol Biochem Behav. 2020;197:173003.
    PubMed     Abstract available
    
    
    
50. SMAIL MA, Smith BL, Nawreen N, Herman JP, et al
    Differential impact of stress and environmental enrichment on corticolimbic circuits.
    Pharmacol Biochem Behav. 2020;197:172993.
    PubMed     Abstract available
    
    
    May 2020
51. PHAM TH, Defaix C, Nguyen TML, Mendez-David I, et al
    Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pharmacol Biochem Behav. 2020;192:172913.
    PubMed     Abstract available
    
    
    
52. AN Q, Li C, Chen Y, Yang Y, et al
    Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses.
    Pharmacol Biochem Behav. 2020;192:172910.
    PubMed     Abstract available
    
    
    March 2020
53. WEI Y, Chang L, Hashimoto K
    A historical review of antidepressant effects of ketamine and its enantiomers.
    Pharmacol Biochem Behav. 2020;190:172870.
    PubMed     Abstract available
    
    
    
54. WITKIN JM
    mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects.
    Pharmacol Biochem Behav. 2020;190:172854.
    PubMed     Abstract available
    
    
    
55. LAINIOLA M, Linden AM, Aitta-Aho T
    Behavioral responses of mGluR3-KO mice to the lipopolysaccharide-induced innate inflammatory reaction.
    Pharmacol Biochem Behav. 2020;190:172852.
    PubMed     Abstract available
    
    
    January 2020
56. DEYAMA S, Duman RS
    Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
    Pharmacol Biochem Behav. 2020;188:172837.
    PubMed     Abstract available
    
    
    
57. POLESZAK E, Wosko S, Slawinska K, Wyska E, et al
    Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.
    Pharmacol Biochem Behav. 2020;188:172833.
    PubMed     Abstract available
    
    
    
58. KATO T, Duman RS
    Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
    Pharmacol Biochem Behav. 2020;188:172827.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.